Since January 22nd, 2026, Accellix is part of bioMérieux, a world leader in the field of in vitro diagnostics.
Learn more about this strategic acquisition.
Cellular Quality Assessment Without Complexity
ACCELLIX™ is Bringing the Power of Flow Cytometry to Cell Therapy Development & Manufacturing.
What is the ACCELLIX Instrument?
This two minute video will give you a lot of insight into the state-of-the-art ACCELLIX Instrument and automated cell phenotyping platform.
Learn More
The ACCELLIX Automated Cell Phenotyping Platform
Instrument
Small footprint bench-top platform, manufacturing suite compatible and fan-less operation that provides minimal maintenance 24/7.
Cartridge
A microfluidic cartridge with unitized, dried-down reagents that require only two minutes of hands-on time for sample preparation, helping improve reproducibility and accuracy.
Software
Automated results analysis with no cytometry expertise required. Configurable software to meet QC requirements with touchscreen interface and easy navigation.
Assays
Off-the-shelf and custom assays for every step in your process.
A Revolution in the science of flow cytometry
Cartridge Based Assays
Only two minutes of hands-on time for sample preparation, helping improve reproducibility and accuracy.
Learn More
Fully Automated
Fully automated data analysis and auto classification process tailored to customer's needs.
Learn More
Contributing to Cell Therapy Development and Manufacturing Around the Globe
ACCELLIX™ platform automates sample preparation, flow cytometry, and data analysis to deliver rapid, standardized results on cell phenotype, enumeration, viability, identity, and purity—enhancing blood starting material optimization and simplifying incoming, in process, and release testing across the entire cell therapy workflow.
